RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Yourgene Health Stock

Yourgene Health P/S 2024

Yourgene Health P/S

0.19

Ticker

YGEN.L

ISIN

GB00BN31ZD89

WKN

A116JH

As of Oct 2, 2024, Yourgene Health's P/S ratio stood at 0.19, a 137.5% change from the 0.08 P/S ratio recorded in the previous year.

The Yourgene Health P/S history

Yourgene Health Aktienanalyse

What does Yourgene Health do?

Yourgene Health PLC is an international life science company specializing in the development and marketing of DNA tests for various areas of health. The company, based in Manchester, England, was founded in 2009 and has been listed on the London Stock Exchange since 2013. The business model of Yourgene Health is to offer genetic tests for a variety of applications in order to improve people's well-being, health, and quality of life. The company has extensive experience in developing DNA diagnostic tests and offers a wide range of solutions for different markets. One of the core divisions of the company is oncology. Here, Yourgene Health PLC develops innovative test methods to identify and combat cancer cells and their growth. Another important area is reproductive health, where the company offers prenatal testing as well as fertility analysis. In Yourgene Health's broad product range, there are prenatal tests for the examination of chromosomal abnormalities in the fetus, tests for the analysis of genetic risks for hereditary diseases or thyroid diseases. The company also offers tests for the detection of bacteria and viruses, which serve as companion tests for infections. One of Yourgene Health's newest products is the Covid-19 PCR test. This test is performed through nasal and throat swabs and can provide an accurate diagnosis of coronavirus infection within a few hours. The test was developed in 2020 and has since proven to be an important measure in containing the pandemic along the test-trace-isolate model. In recent years, Yourgene Health has made numerous collaborations and acquisitions to strengthen its market position in different countries. This includes the acquisition of the US company Elucigene Diagnostics, a provider of DNA test solutions for reproductive health, in 2021. As part of its growth strategy, the company has announced expansion plans for Asia, particularly for China and Japan. For this purpose, the subsidiary Yourgene Health Shanghai was established in 2019. Yourgene Health PLC is an innovative company operating in a rapidly growing market. Through continuous development of new innovative test methods, implementation of collaborations and acquisitions, and expansion into new markets, the company is well positioned to achieve further growth successes and improve global health for consumers. Yourgene Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Yourgene Health's P/S Ratio

Yourgene Health's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Yourgene Health's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Yourgene Health's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Yourgene Health’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Yourgene Health stock

What is the price-to-earnings ratio of Yourgene Health?

The price-earnings ratio of Yourgene Health is currently 0.19.

How has the price-earnings ratio of Yourgene Health changed compared to last year?

The price-to-earnings ratio of Yourgene Health has increased by 137.5% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Yourgene Health high compared to other companies?

Yes, the price-to-earnings ratio of Yourgene Health is high compared to other companies.

How does an increase in the price-earnings ratio of Yourgene Health affect the company?

An increase in the price-earnings ratio of Yourgene Health would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Yourgene Health affect the company?

A decrease in the price-earnings ratio of Yourgene Health would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Yourgene Health?

Some factors that influence the price-earnings ratio of Yourgene Health are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Yourgene Health pay?

Over the past 12 months, Yourgene Health paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Yourgene Health is expected to pay a dividend of 0 GBP.

What is the dividend yield of Yourgene Health?

The current dividend yield of Yourgene Health is .

When does Yourgene Health pay dividends?

Yourgene Health pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Yourgene Health?

Yourgene Health paid dividends every year for the past 0 years.

What is the dividend of Yourgene Health?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Yourgene Health located?

Yourgene Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Yourgene Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Yourgene Health from 10/2/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.

When did Yourgene Health pay the last dividend?

The last dividend was paid out on 10/2/2024.

What was the dividend of Yourgene Health in the year 2023?

In the year 2023, Yourgene Health distributed 0 GBP as dividends.

In which currency does Yourgene Health pay out the dividend?

The dividends of Yourgene Health are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Yourgene Health stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Yourgene Health

Our stock analysis for Yourgene Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Yourgene Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.